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Background: Current publicly reported quality performance measures directly compare primary care to specialty
care. Specialists see short-term patients referred due to poor control of their disease who then return to their local
provider. Our study looked to determine if outcomes measured in short-term care patients differed from those in
long-term care patients and what impact those differences may have on quality performance profiles for specialists.
Methods: Retrospective cohort from a large academic medical Center. Performance was measured as “Optimal
Care” - all or none attainment of goals. Patients with short-term care (<90 days contact) versus long-term care
(>90 days contact) were evaluated for both specialty and primary care practices during the year 2008.
Results: Patients with short-term care had significantly lower “Optimal Care”: 7.2% vs. 19.7% for optimal diabetes
care in endocrinology and 41.3% vs. 53.1% for optimal ischemic vascular disease care in cardiology (p < 0.001).
Combining short and long term care patients lowered overall perceived performance for the specialty practice.
Conclusions: Factors other than quality affect the perceived performance of the specialty practice. Extending
current primary care quality measurement to short-term specialty care patients without adjustment produces
misleading results.
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Since public reporting of performance data can motivate
improvements in the delivery of high quality care [1-3],
a move towards public performance reporting has oc-
curred at the medical group and clinic level. One ex-
ample, Minnesota Community Measurement (MNCM)
was created in 2004 as a collaboration between payers,
providers and employers, with the goal of publicly
reporting quality data to accelerate the improvement of
healthcare in the state of Minnesota [4]. Initial efforts fo-
cused on primary care clinics, providing longitudinal
care, with documented improvement at the provider
level [5] and at the state level with annual gains in many
of these metrics [6]. More recently, public reporting has* Correspondence: nyman.mark@mayo.edu
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unless otherwise stated.broadened to include specialty clinics, which are com-
pared directly with primary care clinics using the same
outcome metrics for diabetes and vascular disease. In
the United States, most insurance plans allow patients to
obtain services either through primary care, delivered by
both general internal medicine and family medicine pro-
viders, or specialty care. However, specialty providers see
two types of patients: those who they care for over the
long-term and those who they care for over the short-
term. Long term patients are generally those managed
over time by the specialist, usually complex patients with
challenging chronic disease control issues; whereas
short-term patients tend to be those who have been re-
ferred for management recommendations and then return
after their consultation to their primary care provider for
continuing care. In a referral center, some of these short-
term patients may still meet the multiple visit attribution
criteria of existing measures. Current quality reporting
does not adequately differentiate between short-term and. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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cohort for assessing specialist quality performance.
Following Donabedian’s model [7], quality can be
assessed using structure, process or outcome measures.
When comparing metrics across providers, measure-
ment definitions become important, particularly for out-
come measures. Patient characteristics have been shown
to influence performance measures for both primary
care and specialty care physicians [8,9]. Alternative
methods of attributing a patient to a provider or clinic
have been shown to impact performance measures and
reported costs [10,11]. Studies comparing the perform-
ance of specialist care to primary care have shown
contradictory results, though there have been methodo-
logical challenges [12]. Studies showing better perform-
ance for specialty care tend to evaluate patients
receiving care over the long-term [9,13]. Laboratory and
physiologic measures used as outcome measures during
a short-term care episode can represent care provided
prior to the measurement and not care received at the
time of the specialist visit. For example, when adjusting
medications, the American Diabetes Association (ADA)
recommends an interval of 90 days prior to reassessment
of the hemoglobin A1C [14]. So a hemoglobin A1C ob-
tained during a short-term care episode (<90 days con-
tact) would reflect the quality of prior care– not the
quality of care delivered by the specialist. We found no
studies evaluating the impact on the perceived perform-
ance of specialty practices when combining short-term
care patients with long-term care patients.
We hypothesized short and long term care patients were
significantly different and if combined together would
cause a change in the perceived quality performance of
specialists. We addressed these questions by comparing
the differences between short and long term patients and
comparing performance metrics between patients seen by
primary care providers (general internal medicine and
family practice) with those seen by specialist providers for
two disease cohorts, diabetes and vascular disease, using




To fully understand the impact on public measures, we cre-
ated our cohorts and assessed outcome measures according
to the current measurement specifications of the Minne-
sota State Quality Measures (as specified by MNCM). We
compared the performance of specialists to primary care
practitioners for two retrospective disease cohorts at a large
academic medical center in Rochester, Minnesota: patients
with diabetes and those with ischemic vascular disease
(IVD). Cohorts were identified using institutional billing
data. To be considered in the measurement population, perMNCM definitions [15], a patient needed to be seen at least
twice during 2007 or 2008 (24 months) within the same
primary care, cardiology or endocrinology clinic. At our in-
stitution, endocrinology and cardiology clinics are referral
clinics staffed by Board-certified specialists, while primary
care and general internal medicine clinics are staffed by
board certified internal medicine and family medicine phy-
sicians. Following the public reporting specifications, we
compared all patients with diabetes seen at our institution
at least twice by an endocrinologist (and not a primary
care provider) to all patients seen at least twice by a pri-
mary care provider. A similar comparison was made for
the IVD cohort between cardiologists and primary care
providers. For each patient, the most recent laboratory
data (hemoglobin A1C and LDL cholesterol) and blood
pressure values were extracted from the electronic med-
ical record (EMR) as specified by MNCM. We defined
short-term care as having the time between the initial and
final visit within the two year window of less than 90 days,
while long-term care was defined as visits with the pro-
vider occurring over more than 90 days. This timeframe
was chosen based on clinical opinion of the minimal time
necessary to see the outcomes of most chronic disease
treatments and was consistent with the ADA recom-
mended reassessment time of hemoglobin A1C. As this
study was based on deidentified patient information used
for public reporting, it was reviewed by the Mayo Clinic
Institutional Review Board (09-008403) and deemed as ex-
empt from further review.
Study population
Patient cohorts were identified using the MNCM pub-
licly reported quality metric definition applied to admin-
istrative billing data [15]. Patients, aged 18 to 75, had to
have at least two visits for diabetes or vascular care
within the years 2007 and 2008 with at least one office
visit of any kind during 2008. Patients who died by
December 31, 2008 were excluded. Diabetes and IVD
visits were defined using ICD-9 codes as outlined in
Table 1.
Measurements
MNCM compares practices on “optimal care” using a
composite “all-or-none” measure that includes a mixture
of process and outcome components. Diabetes requires
values at goal for glucose control using Hemoglobin A1c
(HbA1c) measurement, blood pressure control using
Blood Pressure (BP) measurement, and lipid control
using Low Density Lipoprotein (LDL) measurement,
documentation of non-smoking status and documentation
of daily aspirin use. Vascular care requires values at goal
for BP, LDL, documentation of non-smoking status and
documentation of daily aspirin use. For this study we re-
stricted our assessment to the outcome components of
Table 1 ICD-9 Diagnosis codes
Diabetes
250 – 250.93 Diabetes Mellitus
Ischemic Vascular Disease
410 – 410.92 AMI
411 – 411.89 Post-MI
412 Old AMI
413 – 413.9 Angina Pectoris
414.0 – 414.07 CAD
414.2 Chronic Total Occlusion of Coronary Artery
414.8 Other Chronic Ischemic Heart Disease (IHD)
414.9 Chronic IHD
429.2 Cardiovascular (CV) disease, unspecified
433 – 433.91 Occlusion and stenosis of pre-cerebral arteries
434 – 434.91 Occlusion of cerebral arteries
440.1 Atherosclerosis of renal artery
440.2 – 440.29 Atherosclerosis of native arteries of the
extremities, unspecified
440.4 Chronic Total Occlusion of Artery of the
Extremities
444 – 444.9 Arterial embolism and thrombosis
445 - 445.8 Atheroembolism
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(HbA1c, BP, and LDL) for diabetes and the two physio-
logical parameters (BP and LDL) for ischemic vascular
disease. For public reporting, these measures are electron-
ically extracted. This eliminated the need for extensive
manual chart review. Aspirin (ASA) use and non-smoking
status documentations have high compliance rates in
Minnesota suggesting these two parameters add only a
small portion to the overall optimal care metric [2008
Minnesota statewide average at goal: BP (56%), LDL
(58%), HbA1c (58%) vs. Tobacco (83%), ASA (89%) for
diabetes; and BP (58%), LDL (65%) vs. Tobacco (82%),








N, (%) 417 (15.4%) 2284 (84.6%) 270
Male, % 58.8 55.7 0.240 56.2
Age, Mean (SD) 54.77 (13.26) 57.22 (12.74) <0.001 56.8
Within 120 miles, % 32.6 67.5 <0.001 62.1
MN Resident, % 29.5 63.8 <0.001 58.5
SE MN Resident, % 15.1 45.1 <0.001 40.5
Missing Data, % 22.1 12.2 <0.001 13.7
Optimal Diabetes Care, % 7.2 19.7 <0.001 17.8measures, these assessments are not expected to differ be-
tween short-term and long-term patients. We defined our
modified “optimal care” measure for diabetes as a patient
whose most recent assessment during the measurement
period (2008) was at goal for HbA1c (goal < 7.0% [53
mmol/mol]), LDL (goal < 100 mg/dl), and blood pressure
(goal < 130/80 mmHg). Our “optimal care” measure for
IVD was defined as a patient whose most recent assess-
ment during 2008 was at goal for blood pressure (goal <
130/80 mmHg) and during the period of 10/1/2007 to 12/
31/2008 was at goal for LDL (goal < 100 mg/dl) [MNCM
had allowed 5 quarters of data for LDL]. If values were
not recorded during the measurement time frame, these
were considered missing and not in control (MNCM de-
fines missing values as a failure in performance).
Statistical analysis
For both specialty care and primary care: patients with
short and long term care were compared within each
disease cohort with two sample t-tests for continuous
data and chi-square analysis for categorical data. Assess-
ment of differences on “optimal care” measures between
short and long term care measures were based on logis-
tic regression models incorporating age and sex of
patients.Results
3214 diabetic and 1027 vascular patients were attributed
to primary care providers. Patients who met the visit cri-
teria for inclusion in both primary care and specialty
care were attributed only to primary care (n = 62 diabetic
and n = 60 vascular patients). 2701 diabetic and 1759
vascular patients were attributed to specialist providers,
endocrinology and cardiology, respectively.
For specialty care and primary care, the characteristics
comparing those with short-term care (<90 days) to
those with long-term care (>90 days) are displayed in








1 62 (1.9%) 3152 (98.1%) 3214
56.5 54.3 0.734 54.3
(12.8) 51.7 (12.50) 58.03 (11.07) <0.001 57.9 (11.1)
91.9 98.4 <0.001 98.3
91.9 98.2 <0.001 98.1
91.9 96.6 0.049 96.5
14.5 7.4 0.035 7.5
9.7 18.8 0.068 18.6
Table 3 Ischemic vascular disease – short versus long follow-up










N, (%) 513 (29.2%) 1246 (70.8%) 1759 33 (3.2%) 994 (96.8%) 1027
Male, % 76.2 71.6 0.047 72.9 66.7 74.0 0.343 73.8
Age, Mean (SD) 61.37 (9.48) 63.25 (8.59) <0.001 62.7 (8.85) 60.24 (9.45) 62.88 (8.79) 0.091 62.8 (8.81)
Within 120 miles, % 46.2 56.3 <0.001 53.4 90.9 97.2 0.038 97.0
MN Resident, % 45.2 52.9 0.004 50.7 90.9 97.4 0.027 97.2
SE MN Resident, % 23.2 32.7 <0.001 29.9 90.9 95.2 0.268 95.1
Missing Data, % 10.1 7.6 0.084 8.3 3.0 6.3 0.439 6.2
Optimal IVD Care, % 41.3 53.1 <0.001 49.7 36.4 51.0 0.098 50.5
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term patients with diabetes (15.4% vs. 1.9%, p < 0.001)
and patients with IVD (29.2% vs. 3.2%, p < 0.001) than
primary care providers. Missing laboratory values were
more common in short-term care patients than long-
term patients (diabetes: 21.1% vs. 9.4%, p < 0.001; IVD:
9.7% vs. 7.1%, p = 0.036) resulting in more missing data
for the specialist than the primary care providers. Fur-
thermore, the percentage of patients at “optimal care”
was statistically lower for those with short-term care
than those with long-term care [diabetes: 7.5% versus
23.7% (p < 0.001); IVD: 41.0% versus 52.2% (p < 0.001)].
After adjustment for patient age and sex, patients with
short-term care are 4.6 times less likely to meet diabetes
optimal care measures and 2.5 times less likely to meet
IVD optimal care measures. Short-term care patients
seeing specialists are also significantly less likely to beFigure 1 Diabetes performance – primary care vs. specialty.from the nearby geographic area (within 120 miles) for
diabetes [32.6% versus 67.5% (p < 0.001)] and for IVD
[46.2% versus 56.3% (p < 0.001), reflecting the nature of
our national referral practice.
Figure 1 shows the impact of including short-term pa-
tients among the diabetes cohort on the comparison of
the performance of endocrinology to the performance of
primary care. As currently defined by MNCM (both those
with short and long term care), endocrinology had a lower
percentage of patients at “optimal care” than did primary
care. However, when restricting the measurement to pa-
tients with long-term care only (e.g., continuing care pa-
tients), endocrinology had a higher percentage of patients
at “optimal care” than did primary care.
Figure 2 shows the similar impact of the definition of
these patients on the performance of cardiology to the
performance of primary care. Using the Minnesota
Figure 2 Ischemic vascular disease performance – primary care vs. specialty.
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those with short and long term care), cardiology had a
lower percentage of patients at “optimal care” than did
primary care. However, when restricting the measure-
ment to patients with long-term care only (continuing
care patients), cardiology had a higher percentage of pa-
tients at “optimal care” than did primary care.
Discussion
Using definitions currently used for public reporting, we
compared a modified “optimal care” quality metric be-
tween primary care and specialty practice for two disease
cohorts, based on time between each patient’s first and
last visit during the study time frame. The measures re-
ported in the Minnesota Quality Report [17] to assess
the performance of care for diabetes and ischemic vascu-
lar disease consist of outcome metrics that clinically re-
flect care delivered over the long-term, and not care
delivered over the short-term. However, these health
outcome measures include both short and long term
care patients in the measurement cohort. We showed
that specialists have a significantly higher percentage of
patients receiving short-term care. We also showed pa-
tients receiving short–term care have a significantly
lower percentage at “optimal care”. When combining pa-
tients with short and long-term care, the percentage of
patients at “optimal care” for the specialist was lower
when compared to primary care. However, when com-
paring only patients with long-term care, the percentage
of patients at “optimal care” was actually higher for the
specialist when compared to primary care. Our findings
are similar to specialty clinics throughout Minnesotawhere specialty clinics rank lower than primary care
clinics with regards to performance according to the
specified MNCM measurements.
Why were there fewer patients at “optimal” care in the
short-term care patient pool? As outlined above, many
had been referred to the specialist because of their poor
control or complexity. Additionally, patients may have
had laboratory measures performed at home just prior
to the measurement period and not repeated at the re-
ferral site within the measurement period, due to their
intended return to their local provider. Laboratory
values reported from outside sources, while used to
make clinical decisions, are often not captured in
discrete fields in our electronic record and therefore are
considered missing laboratory results (counted as a fail-
ure) for assessment purposes. Furthermore, short-term
patients had insufficient follow-up time for A1C mea-
sures to reflect any treatment recommendations follow-
ing their specialty visits.
Based on our analysis, a more equitable comparison
between specialty practice and primary care would be to
compare the patients they are caring for over the long-
term. Restricting the measured population to longer-
term patients could be easily attained by modifying the
denominator definition to require two visits within two
years to be at least 90 days apart. Applied across all
clinics, this would reduce the demonstrated bias for spe-
cialty practice performance metrics, with minimal im-
pact on primary care performance. Alternatively, one
could compare cohorts of patients seen within similar
settings – specialty care to specialty care and primary
care to primary care. Finally, one could eliminate public
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ity improvement only.
Our study was limited by several factors. It was per-
formed at only one institution, an academic center with
a geographically large referral practice. Though similar
results may be expected at other specialty practices, the
magnitude of the difference between referred (short-
term) and continuity (long-term) patients will depend
on the mix of these patients and may be smaller, espe-
cially at community specialty practices. We also were
not able to determine whether most of the differences
between short-term and long-term patients were due to
initial disease severity, other differences between the pa-
tients, or treatment differences. However, due to the
short exposure of these chronically ill patients to the
specialty provider, we feel that this issue does not impact
our conclusions. As in MNCM reporting, our study re-
lied only on data available by the reporting system to the
clinicians, and no active follow-up was used to obtain
more recent laboratory or blood pressure results. Fur-
thermore, the MNCM measurements may be subject to
other criticisms (e.g., use of the last recorded measure to
reflect chronic disease control, lack of adjustment for
multiple chronic disease, treating missing laboratory
values as lack of disease control). We were not able to
address all of these issues in this study.Conclusions
Value in health care has been defined as the health out-
comes achieved per dollar spent [18]. When comparing
value across different providers, the health outcomes
must be risk adjusted for the patient’s initial condition to
prevent bias [19]. How the measured cohort is defined
can also affect the perceived performance [9]. We have
demonstrated that the perceived performance or public
“rank” using current Minnesota State mandated quality
metrics for the specialty practice can be impacted by the
percent of short-term patients seen. Patients receiving
short-term care that are included within the cohort of
an outcome measure add an additional confounding fac-
tor that must be adjusted for when designing outcome
measures. These results are important nationally as
these same MNCM diabetes and vascular optimal care
metrics have been endorsed by the National Quality
Forum [20] and are being incorporated in the Medicare
program Group Provider Quality Reporting System.
Health care policy makers and public quality reporting ini-
tiatives must be aware that the same measure applied
across different patient populations is not always equit-
able. As we move towards value based payment methods,
appropriate adjustments must be applied to outcome
measures and the population assessed in order to fairly re-
imburse providers across different types of practices.Physicians and clinics must be held accountable for the
quality of their care, but only the care within their control.
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